FAMILIES OF SPINAL MUSCULAR ATROPHY has a total of 14 patent applications. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), United States and New Zealand. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are NEWLAXANT LLC, MERCURY THERAPEUTICS INC and BOEHRINGER INGELHEIM CHEMICALS.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 3 | |
#3 | New Zealand | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | Hong Kong | 1 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Singh Jasbir | 14 |
#2 | Gurney Mark E | 14 |
Publication | Filing date | Title |
---|---|---|
AU2007281217A1 | 2,4-Diaminoquinazolines for spinal muscular atrophy |